Time-dependent prognostic scoring system for predicting survival and leukemic evolution in myelodysplastic syndromes

Journal of Clinical Oncology

Volumn 25, Issue 23, 2007, Pages 3503-3510

  Malcovati, Luca ^a   Germing, Ulrich ^a   Kuendgen, Andrea ^a   Della Porta, Matteo G ^a   Pascutto, Cristiana ^a   Invernizzi, Rosangela ^a   Giagounidis, Aristoteles ^a   Hildebrandt, Barbara ^a   Bernasconi, Paolo ^a   Knipp, Sabine ^a   Strupp, Corinna ^a   Lazzarino, Mario ^a   Aul, Carlo ^a   Cazzola, Mario ^a  

^a UNIVERSITY OF PAVIA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ACCURACY; AGED; ARTICLE; CANCER CLASSIFICATION; CANCER RISK; CANCER SURVIVAL; CONTROLLED STUDY; DISEASE COURSE; ERYTHROCYTE TRANSFUSION; FEMALE; HUMAN; KARYOTYPE; LEUKEMIA; MAJOR CLINICAL STUDY; MALE; MYELODYSPLASTIC SYNDROME; PRIORITY JOURNAL; PROGNOSIS; PROPORTIONAL HAZARDS MODEL; SCORING SYSTEM; WORLD HEALTH ORGANIZATION;

BLOOD TRANSFUSION; COHORT STUDIES; CYTOGENETICS; DISEASE PROGRESSION; FEMALE; FOLLOW-UP STUDIES; HUMANS; KARYOTYPING; LEUKEMIA; MALE; MYELODYSPLASTIC SYNDROMES; NEOPLASM STAGING; PROGNOSIS; TIME FACTORS; TREATMENT OUTCOME;

EID: 34548219420     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.2006.08.5696     Document Type: Article

References (28)

1. Cazzola M, Malcovati L: Myelodysplastic syndromes: Coping with ineffective hematopoiesis. N Engl J Med 352:536-538, 2005
2. Bennett JM, Catovsky D, Daniel MT, et al: Proposals for the classification of the myelodysplastic syndromes. Br J Haematol 51:189-199, 1982
3. Mufti GJ, Stevens JR, Oscier DG, et al: Myelodysplastic syndromes: A scoring system with prognostic significance. Br J Haematol 59:425-433, 1985
4. Sanz GF, Sanz MA, Vallespi T, et al: Two regression models and a scoring system for predicting survival and planning treatment in myelodysplastic syndromes: A multivariate analysis of prognostic factors in 370 patients. Blood 74:395-408, 1989
5. Aul C, Gattermann N, Heyll A, et al: Primary myelodysplastic syndromes: Analysis of prognostic factors in 235 patients and proposals for an improved scoring system. Leukemia 6:52-59, 1992
6. Morel P, Declercq C, Hebbar M, et al: Prognostic factors in myelodysplastic syndromes: Critical analysis of the impact of age and gender and failure to identify a very-low-risk group using standard mortality ratio techniques. Br J Haematol 94:116-119, 1996
7. Greenberg P, Cox C, LeBeau MM, et al: International scoring system for evaluating prognosis in myelodysplastic syndromes. Blood 89:2079-2088, 1997
8. Vardiman JW, Harris NL, Brunning RD: The World Health Organization (WHO) classification of the myeloid neoplasms. Blood 100:2292-2302, 2002
9. Germing U, Gattermann N, Strupp C, et al: Validation of the WHO proposals for a new classification of primary myelodysplastic syndromes: A retrospective analysis of 1600 patients. Leuk Res 24:983-992, 2000
10. Nosslinger T, Reisner R, Koller E, et al: Myelodysplastic syndromes, from French-American-British to World Health Organization: Comparison of classifications on 431 unselected patients from a single institution. Blood 98:2935-2941, 2001
11. Howe RB, Porwit-MacDonald A, Wanat R, et al: The WHO classification of MDS does make a difference. Blood 103:3265-3270, 2004
12. Malcovati L, Della Porta M, Pascutto C, et al: Prognostic factors and life expectancy in myelodysplastic syndromes classified according to WHO criteria: A basis for clinical decision-making. J Clin Oncol 23:7594-7603, 2005
13. Matsuda A, Germing U, Jinnai I, et al: Difference in clinical features between Japanese and German patients with refractory anemia in myelodysplastic syndromes. Blood 106:2633-2640, 2005
14. Germing U, Strupp C, Kuendgen A, et al: Prospective validation of the WHO proposals for the classification of myelodysplastic syndromes. Haematologica 91:1596-1604, 2006
15. Malcovati L, Della Porta MG, Cazzola M: Predicting survival and leukemic evolution in patients with myelodysplastic syndrome. Haematologica 91: 1588-1590, 2006
16. Sierra J, Perez WS, Rozman C, et al: Bone marrow transplantation from HLA-identical siblings as treatment for myelodysplasia. Blood 100:1997-2004, 2002
17. Cutler CS, Lee SJ, Greenberg P, et al: A decision analysis of allogeneic bone marrow transplantation for the myelodysplastic syndromes: Delayed transplantation for low-risk myelodysplasia is associated with improved outcome. Blood 104:579-585, 2004
18. Standing Committee on Human Cytogenetic Nomenclature: ISCN: An International System for Human Cytogenetic Nomenclature - Report of the Standing Committee on Human Cytogenetic Nomenclature. Birth Defects Orig Artic Ser 21:1-117, 1985
19. Alessandrino EP, Amadori S, Barosi G, et al: Evidence- and consensus-based practice guidelines for the therapy of primary myelodysplastic syndromes: A statement from the Italian Society of Hematology. Haematologica 87:1286-1306, 2002
20. Bowen D, Culligan D, Jowitt S, et al: Guidelines for the diagnosis and therapy of adult myelodysplastic syndromes. Br J Haematol 120:187-200, 2003
21. Vardiman JW: Hematopathological concepts and controversies in the diagnosis and classification of myelodysplastic syndromes. Hematology Am Soc Hematol Educ Program 199-204, 2006
22. Malcovati L, Della Porta MG, Lunghi M, et al: Flow cytometry evaluation of erythroid and myeloid dysplasia in patients with myelodysplastic syndrome. Leukemia 19:776-783, 2005
23. Della Porta MG, Malcovati L, Invernizzi R, et al: Flow cytometry evaluation of erythroid dysplasia in patients with myelodysplastic syndrome. Leukemia 20:549-555, 2006
24. Pellagatti A, Cazzola M, Giagounidis AA, et al: Gene expression profiles of CD34+ cells in myelodysplastic syndromes: Involvement of interferon- stimulated genes and correlation to FAB subtype and karyotype. Blood 108:337-345, 2006
25. Pfeilstocker M, Reisner R, Nosslinger T, et al: Cross-validation of prognostic scores in myelodysplastic syndromes on 386 patients from a single institution confirms importance of cytogenetics. Br J Haematol 106:455-463, 1999
26. Sole F, Luno E, Sanzo C, et al: Identification of novel cytogenetic markers with prognostic significance in a series of 968 patients with primary myelodysplastic syndromes. Haematologica 90: 1168-1178, 2005
27. Deschler B, de Witte T, Mertelsmann R, et al: Treatment decision-making for older patients with high-risk myelodysplastic syndrome or acute myeloid leukemia: Problems and approaches. Haematologica 91:1513-1522, 2006
28. Kuendgen A, Strupp C, Aivado M, et al: Myelodysplastic syndromes in patients younger than age 50. J Clin Oncol 24:5358-5365, 2006